Sai Praneeth Reddy Bathena
机构: UNIVERSITY OF MINNESOTA
每年引用次数
引用次数
引用: 840
H-指数: 15
I10-指数 : 16
出版物: 33
Bile acids as biomarkers for hepatobiliary diseases
Sai Praneeth Reddy Bathena
2013
Association of High Body Mass Index with Response Outcomes in Patients with CML-CP Treated with Dasatinib Versus Imatinib in the First Line: Exploratory Post Hoc Analysis of the Phase 3 DASISION Trial
Massimo Breccia , Jorge E. Cortes , Neil P Shah , Giuseppe Saglio
Blood 134 4155 -4155
2019
CML-023: Relationship Between High Body Mass Index (BMI) and Treatment Outcomes in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Dasatinib or Imatinib: Retrospective Analysis of the Phase 3 DASISION Trial
Massimo Breccia , Jorge E. Cortes , Neil P. Shah , Giuseppe Saglio
Clinical Lymphoma Myeloma and Leukemia 20 S230
2020
Prediction of drug--drug interaction potential mediated by transporters between dasatinib and metformin, pravastatin, and rosuvastatin using physiologically based pharmacokinetic modeling
Ming Chang , Sai Bathena , Lisa J Christopher , Hong Shen
Cancer Chemotherapy and Pharmacology 89 ( 3) 383 -392
2
2022
Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids
Lirui Wang , Phillipp Hartmann , Michael Haimerl , Sai P. Bathena
Journal of Hepatology 60 ( 6) 1259 -1267
17
2014
A Major Human Oral Lysophosphatidic Acid Species, LPA 18:1, Regulates Novel Genes in Human Gingival Fibroblasts.
D. Roselyn Cerutis , Michael D. Weston , Yazen Alnouti , Sai P. Bathena
Journal of Periodontology 86 ( 5) 713 -725
4
2015
Rapid and reliable quantitation of amino acids and myo-inositol in mouse brain by high performance liquid chromatography and tandem mass spectrometry
Sai P. Bathena , Jiangeng Huang , Adrian A. Epstein , Howard E. Gendelman
Journal of Chromatography B 893-894 15 -20
27
2012
Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1).
J. Huang , S. P. Bathena , J. Tong , M. Roth
Xenobiotica 40 ( 3) 184 -194
40
2010
Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.
S.P. Bathena , J. Huang , M.E. Nunn , T. Miyamoto
Journal of Pharmaceutical and Biomedical Analysis 56 ( 2) 402 -407
21
2011
A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors.
Yuxiang Ma , Wenfeng Fang , Hongyun Zhao , Sai Praneeth Bathena
Oncologist 26 ( 4)
1
2021
Focused beam microwave irradiation for measures of neural metabolites in a murine model of neuroAIDS
Adrian Epstein , Sai Praneeth Bathena , Sidra Akhter , Larisa Poluektova
JOURNAL OF NEUROVIROLOGY 18 34 -34
2012
Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors
Yue Zhao , Zheyi Hu , Sai Praneeth Bathena , Sarah Keidel
Clinical Cancer Research OF1 -OF9
1
2024
Pharmacokinetic-pharmacodynamic model of topiramate-induced working memory impairment in healthy volunteers
Samuel P Callisto , Angela K Birnbaum , Christopher M Barkley , Sai Praneeth Bathena
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45 S98 -S99
2018
Kinetics of Bile Acid Sulfation by Human Sulfotransferase 2A1 (SULT2A1)
Yazen Alnouti , Jiangeng Huang , Sai Praneeth Bathena
DRUG METABOLISM REVIEWS 42 227 -227
2010
Laboratory Macrophage Screening Assays Predict Pharmacokinetics of Controlled Release of Nano-formulated Antiretroviral Drugs In Vivo
A Nowacek , Z Ma , J Mcmillan , J Huang
JOURNAL OF NEUROIMMUNE PHARMACOLOGY 5 S31 -S32
2010
Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
Adrian A Epstein , Prabagaran Narayanasamy , Prasanta K Dash , Robin High
Journal of Neuroimmune Pharmacology 8 ( 5) 1224 -1238
27
2013
INVESTIGATING TRANSPORTER-MEDIATED DRUG-DRUG INTERACTIONS (DDIS) OF DASATINIB USING A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL.
M Chang , S Bathena , L Christopher , H Shen
CLINICAL PHARMACOLOGY & THERAPEUTICS 109 S7 -S7
2021
A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab+ relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)
GV Long , R Gutzmer , A Haydon , E Muñoz Couselo
EJC Skin Cancer 2
2024
SC-435, an Inhibitor of ASBT, Improves Liver Function in a Rat Partial Bile Duct Ligation Model of Cholestasis
Lirui Wang , Phillipp Hartmann , Michael Haimerl , Sai P Bathena
POPULATION PHARMACOKINETICS OF RELATLIMAB, A FULLY HUMAN LAG-3-SPECIFIC ANTIBODY, IN PATIENTS WITH ADVANCED SOLID TUMORS AND RELAPSED OR REFRACTORY B-MALIGNANCIES.
J Zhang , SP Bathena , S Chapel , E Briggs
CLINICAL PHARMACOLOGY & THERAPEUTICS 105 S116 -S117
2019